Enes S R, Mckenna D, Santos C D, et al. Inflammatory microenvironment in ARDS patients polarize clinically utilized MSCs towards a pro-inflammatory MSC phenotype[J]. Cytotherapy, 2020, 22(5):S99.
[9]
Holloway T L, Meenakshi R, Cap A P, et al. The association between the Th-17 immune response and pulmonary complications in a trauma ICU population[J]. Cytokine, 2020, 76(2): 328-333.
Yang J W, Jiang P, Wang W W, et al. The Controversy about the effects of different doses of corticosteroid treatment on clinical outcomes for acute respiratory distress syndrome patients: an observational study[J]. Front Pharmacol , 2021,12:722537.
[17]
Lai C, Adda I, Teboul J L, et al. Effects of prone positioning on venous return in patients with acute respiratory distress syndrome[J]. Crit Care Med, 2021,49(5):781-789.
[18]
Wang M, Zhang T, Li L, et al. Protective effects of HY1702 on lipopolysaccharide-induced mild acute respiratory distress syndrome in mice[J]. Eur J Pharmacol, 2020,887:173563.
Mohammed A, Alghetaa H, Zhou J, et al. Protectiveeffects of Δ9-Tetrahydrocannabinol against enterotoxin-induced acute respiratory distress syndrome is mediated by modulation of microbiota[J]. Br J Pharmacol, 2020,177(22):5078-5095
[21]
Kheyfets V O, Lammers S R, Wagner J, et al. PEEP/ ARDSNet scale grouping of a single ventilator for two patients: modeling tidal volume response[J]. Respiratory Care, 2020, 65(8):1094-1103.
[22]
Dan S K, Panigada M, Bottino N, et al. Changes in shunt, ventilation/perfusion mismatch, and lung aeration with PEEP in patients with ARDS: a prospective single-arm interventional study[J]. Critical Care, 2020,24(1):111.
Yang G, Hei M, Xue Z, et al. Effects of less invasive surfactant administration (LISA) via a gastric tube on the treatment of respiratory distress syndrome in premature infants aged 32 to 36 weeks[J]. Medicine (Baltimore), 2020,99(9):e19216.
Holloway T L, Meenakshi R, Cap A P, et al. The association between the Th-17 immune response and pulmonary complications in a trauma ICU population[J]. Cytokine,2020,76(2): 328-333.
Zhang X, Xiang A P. Mesenchymal stromal cells alleviates experimental acute respiratory distress syndrome through the cholinergic anti-inflammatory pathway[J]. Cytotherapy, 2020, 22(5):S12-S13.
[30]
Sun X, Liu Y, Li N, et al. The safety and efficacy of airway pressure release ventilation in acute respiratory distress syndrome patients: a PRISMA-compliant systematic review and meta-analysis[J]. Medicine, 2020, 99(1):e18586.
2023, Vol. 34 
